Next Article in Journal
Self-Reported Psychosomatic Complaints and Conduct Problems in Swedish Adolescents
Next Article in Special Issue
Ovarian Tissue Cryopreservation in Children and Adolescents
Previous Article in Journal
Impact of Intubator’s Training Level on First-Pass Success of Endotracheal Intubation in Acute Care Settings: A Four-Center Retrospective Study
Previous Article in Special Issue
A Mixed-Longitudinal Study of Height Velocity of Greek Schoolchildren and the Milestones of the Adolescent Growth Spurt
 
 
Systematic Review
Peer-Review Record

Identification of Genetic Causes in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome: A Systematic Review of the Literature

Children 2022, 9(7), 961; https://doi.org/10.3390/children9070961
by Varvara Ermioni Triantafyllidi 1,*, Despoina Mavrogianni 2, Andreas Kalampalikis 1, Michael Litos 3, Stella Roidi 1 and Lina Michala 1
Reviewer 1:
Reviewer 2: Anonymous
Children 2022, 9(7), 961; https://doi.org/10.3390/children9070961
Submission received: 5 June 2022 / Revised: 19 June 2022 / Accepted: 22 June 2022 / Published: 27 June 2022

Round 1

Reviewer 1 Report

 

Review of children-1781226

Identification of genetic causes in Mayer–Rokitansky–Küster– Hauser (MRKH) syndrome: A systematic review of the literature

Varvara Ermioni Triantafyllidi, Despoina Mavrogianni, Andreas Kalampalikis, Michael Litos, Stella Roidi, Lina Michala

 

General comments

This manuscript presents the systematic review of the genetic causes associated with MRKH syndrome and Congenital Uterine Anomalies. The main research findings of this paper will be important for the full understanding of these syndrome.

In my opinion, a substantial revision is needed to make this manuscript suitable for publication.

I have found a few issues that, once addressed, will improve the manuscript.

 

Specific comments

1.      How did the authors define the suspected genes involved?

2.      Are there any differences in the suspected genes between Type1 and Type2?.

3.      Gene names should be replaced with italic.

4.      The term “mutation” is not applicable in clinical.

Current guidelines of authorative organizations now also recommend to use neutral terms like “variant” and “change” only (see http://varnomen.hgvs.org/bg-material/basics/).

5.      In discussion, what the differences between table 2 and lists of chromosomal regions?

6.      In discussion line 243, what the meaning of “18q.1”? I did not follow this chromosomal region.

7.      The authors lost two thirds of cases (84/130 records). I guess type 1 patients were not performed further studies and were not reported. The authors need to describe its limitations.

8.      Eligible articles found from the bibliography of the records (n = 28) would be added in supplementary table.

9.      The size of "," between references in the table is too large.

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

Dear authors the manuscript is well-written, good references. 

You highlighted the main genetic mutations for Rokitansky syndrome presented in litarature. 

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop